Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1

• 主要な著者: Zirui Zhao (著者), Shilei Yang (著者), Yawen Deng (著者), Liang Wang (著者), Yifen Zhang (著者), Zhenyu Feng (著者), Han Li (著者), Zhongchao Chi (著者), Yunpeng Xie (著者), Deshi Dong (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Doxorubicin (DOX) leads to myocardial cell damage and irreversible heart failure, which limits the clinical application of DOX. Naringin has biological functions of inhibiting inflammation, oxidative stress and apoptosis. Our aim was to investigate whether Naringin could prevent DOX-related cardioto...